Fig. 1From: A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptidesSchematic structures of DOTA-DX600, NODAGA-DX600, HBED-CC-DX600 (red) for targeting ACE2 and DOTA-BPP9a (yellow) for targeting ACEBack to article page